Setback to Emcure: NPPA refers back price fixation issue of Darunavir, Ritonavir FDC to DoP Medical Dialogues Team9 Aug 2021 8:44 AM GMTNew Delhi: Holding that data is not available, the National Pharmaceuticals Pricing Authority (NPPA) has referred the matter of fixing the retail price...
NIPER Guwahati awards degree to 140 students in 4th Convocation Sanchari Chattopadhyay13 July 2021 3:45 AM GMTGuwahati: The National Institute of Pharmaceutical Education and Research (NIPER), Guwahati celebrated its 4th Convocation on Saturday and awarded degr...
DoP directs NPPA to fix price of Darunavir, Ritonavir for Emcure Pharma Medical Dialogues Team29 Jun 2021 11:39 AM GMTNew Delhi: The Department of Pharmaceuticals (DoP), has recently directed the National Pharmaceuticals Pricing Authority (NPPA) to fix the retail price...
DoP invites applications under PLI scheme for manufacturing KSMs, drug intermediates, APIs Medical Dialogues Team14 Jun 2021 4:00 AM GMTNew Delhi: With an aim to promote Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingred...
DoP issues operational guidelines for PLI Scheme for pharma industry Medical Dialogues Team5 Jun 2021 4:30 AM GMTNew Delhi: With an aim to enhance India's manufacturing capabilities by increasing investment and production in the pharmaceutical sector and to contri...
DoP invites applications under PLI scheme to boost Medical Device manufacturing, Details Medical Dialogues Team2 May 2021 6:00 AM GMTNew Delhi: In order to boost domestic manufacturing and attract large investments in the Medical Device Sector, through a recent notice, the Government...
Cipla to distribute Govt allocated stock of COVID drug tocilizumab to states Farhat Nasim29 April 2021 1:00 PM GMTFresh limited stock of Covid drug tocilizumab has now been imported and is available with lone marketer company Cipla for marketing and distribution...
19 Medical Devices added to public procurement policy, Details Farhat Nasim30 March 2021 12:59 PM GMTNew Delhi: Incorporating in the revised guidelines of the public procurement policy, the Department of Pharmaceuticals (DoP) has notified 19 medical de...
Liberalise regulatory system, particularly for drug approvals: Zydus Group Chairman to Govt Farhat Nasim26 Feb 2021 1:42 PM GMTZydus Group Chairman Pankaj R Patel said the pharma industry can grow to USD 80 90 billion in turnover with normal growth rate but with new...
Department Of Pharmaceuticals to release vacancies for Consultants, Young Professionals; Details Farhat Nasim20 Sep 2020 6:00 AM GMTNew Delhi: Through a recent release, the Department of Pharmaceuticals (DoP) has informed about the hiring of Non-technical Consultants in the departme...
S Aparna takes charge as Secretary, Department of Pharmaceuticals ruchika19 Sep 2020 9:06 AM GMTNew Delhi: The Appointments Committee of the Cabinet recently appointed Senior bureaucrat, S Aparna, as Secretary, Department of Pharmaceuticals (DoP),...
Schemes for bulk drug, medical device parks to attract investment of about Rs 77900 crore, says DV Sadananda Gowda ruchika23 Aug 2020 5:00 AM GMTShri Gowda informed that the schemes for development of bulk drug & medical device parks are expected to attract cumulative investment of about Rs...
